STRS Ohio’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

STRS Ohio’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-900	Closed	-$43K	–	2326
2020 Q1	$43K	Buy	+900	New	+$41.9K	﹤0.01%	1805
2017 Q2	–	Sell	-2,600	Closed	-$55K	–	2057
2017 Q1	$55K	Hold	2,600	–	–	﹤0.01%	1765
2016 Q4	$39K	Buy	+2,600	New	+$35.3K	﹤0.01%	1821

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

STRS Ohio's RARX Position: Q2 2020 in Review

STRS Ohio sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 900 shares — an estimated $43K sold.

STRS Ohio first reported a position in RARX in Q4 2016 and held it in 3 quarters. The position peaked at $55K in Q1 2017. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

STRS Ohio reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
STRS Ohio sold 900 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $43K.
STRS Ohio first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2016 and held it in 3 quarters.
STRS Ohio's Ra Pharmaceuticals, Inc. Common Stock position peaked at $55K in Q1 2017.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.